Literature DB >> 11601972

Monomeric solution structure of the prototypical 'C' chemokine lymphotactin.

E S Kuloglu1, D R McCaslin, M Kitabwalla, C D Pauza, J L Markley, B F Volkman.   

Abstract

Lymphotactin, the sole identified member of the C class of chemokines, specifically attracts T lymphocytes and natural killer cells. This 93-residue protein lacks 2 of the 4 conserved cysteine residues characteristic of the other 3 classes of chemokines and possesses an extended carboxyl terminus, which is required for chemotactic activity. We have determined the three-dimensional solution structure of recombinant human lymphotactin by NMR spectroscopy. Under the conditions used for the structure determination, lymphotactin was predominantly monomeric; however, pulsed field gradient NMR self-diffusion measurements and analytical ultracentrifugation revealed evidence of dimer formation. Sequence-specific chemical shift assignments were determined through analysis of two- and three-dimensional NMR spectra of (15)N- and (13)C/(15)N-enriched protein samples. Input for the torsion angle dynamics calculations used in determining the structure included 1258 unique NOE-derived distance constraints and 60 dihedral angle constraints obtained from chemical-shift-based searching of a protein conformational database. The ensemble of 20 structures chosen to represent the structure had backbone and heavy atom rms deviations of 0.46 +/- 0.11 and 1.02 +/- 0.14 A, respectively. The results revealed that human lymphotactin adopts the conserved chemokine fold, which is characterized by a three-stranded antiparallel beta-sheet and a C-terminal alpha-helix. Two regions are dynamically disordered as evidenced by (1)H and (13)C chemical shifts and [(15)N]-(1)H NOEs: residues 1-9 of the amino terminus and residues 69-93 of the C-terminal extension. A functional role for the C-terminal extension, which is unique to lymphotactin, remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11601972      PMCID: PMC3826542          DOI: 10.1021/bi011106p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  56 in total

Review 1.  International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Authors:  P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

2.  CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding.

Authors:  J S Laurence; C Blanpain; J W Burgner; M Parmentier; P J LiWang
Journal:  Biochemistry       Date:  2000-03-28       Impact factor: 3.162

3.  Solution structure of the human CC chemokine 2: A monomeric representative of the CC chemokine subtype.

Authors:  H Sticht; S E Escher; K Schweimer; W G Forssmann; P Rösch; K Adermann
Journal:  Biochemistry       Date:  1999-05-11       Impact factor: 3.162

4.  The solution structure of the anti-HIV chemokine vMIP-II.

Authors:  A C Liwang; Z X Wang; Y Sun; S C Peiper; P J Liwang
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

5.  Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.

Authors:  G S Kuschert; F Coulin; C A Power; A E Proudfoot; R E Hubbard; A J Hoogewerf; T N Wells
Journal:  Biochemistry       Date:  1999-09-28       Impact factor: 3.162

6.  Sensitivity of human immunodeficiency virus infection to various alpha, beta and gamma chemokines.

Authors:  Giampaolo Greco; Carl Mackewicz; Jay A Levy
Journal:  J Gen Virol       Date:  1999-09       Impact factor: 3.891

7.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology.

Authors:  G Cornilescu; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

8.  Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine.

Authors:  A Amara; O Lorthioir; A Valenzuela; A Magerus; M Thelen; M Montes; J L Virelizier; M Delepierre; F Baleux; H Lortat-Jacob; F Arenzana-Seisdedos
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

9.  Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8.

Authors:  Y Q Qian; K O Johanson; P McDevitt
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

10.  Backbone dynamics of the human CC-chemokine eotaxin.

Authors:  J Ye; K L Mayer; M J Stone
Journal:  J Biomol NMR       Date:  1999-10       Impact factor: 2.835

View more
  25 in total

Review 1.  Converting a protein into a switch for biosensing and functional regulation.

Authors:  Margaret M Stratton; Stewart N Loh
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

Review 2.  Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function.

Authors:  C L Salanga; T M Handel
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

Review 3.  Proteins that switch folds.

Authors:  Philip N Bryan; John Orban
Journal:  Curr Opin Struct Biol       Date:  2010-06-28       Impact factor: 6.809

4.  Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions.

Authors:  E Sonay Kuloğlu; Darrell R McCaslin; John L Markley; Brian F Volkman
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

5.  Structure-function guided modeling of chemokine-GPCR specificity for the chemokine XCL1 and its receptor XCR1.

Authors:  Jamie C Fox; Monica A Thomas; Acacia F Dishman; Olav Larsen; Takashi Nakayama; Osamu Yoshie; Mette Marie Rosenkilde; Brian F Volkman
Journal:  Sci Signal       Date:  2019-09-03       Impact factor: 8.192

6.  Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions.

Authors:  Andrzej Stanisław Cieplak
Journal:  PLoS One       Date:  2017-09-18       Impact factor: 3.240

7.  Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily.

Authors:  Jamie C Fox; Takashi Nakayama; Robert C Tyler; Tara L Sander; Osamu Yoshie; Brian F Volkman
Journal:  Cytokine       Date:  2014-12-11       Impact factor: 3.861

8.  On-column refolding of recombinant chemokines for NMR studies and biological assays.

Authors:  Christopher T Veldkamp; Francis C Peterson; Paulette L Hayes; Jessie E Mattmiller; John C Haugner; Norberto de la Cruz; Brian F Volkman
Journal:  Protein Expr Purif       Date:  2006-09-24       Impact factor: 1.650

9.  Cytomegalovirus CC chemokine promotes immune cell migration.

Authors:  Jennifer Vomaske; Michael Denton; Craig Kreklywich; Takeshi Andoh; Jessica M Osborn; Daniel Chen; Ilhem Messaoudi; Susan L Orloff; Daniel N Streblow
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

10.  Interconversion between two unrelated protein folds in the lymphotactin native state.

Authors:  Robbyn L Tuinstra; Francis C Peterson; Snjezana Kutlesa; E Sonay Elgin; Michael A Kron; Brian F Volkman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.